InvestorsHub Logo
Followers 79
Posts 4556
Boards Moderated 0
Alias Born 05/25/2013

Re: ash111 post# 2284

Wednesday, 05/24/2017 9:14:48 AM

Wednesday, May 24, 2017 9:14:48 AM

Post# of 8305
All we need to know this morning in 1 paragraph.

The U.S. Patent and Trademark Office has issued a patent (U.S. Patent No. 9,636,408) protecting the composition and manufacture of the unique TNX-102 SL formulation. The Protectic™ protective eutectic and Angstro-Technology™ formulation claimed in the patent are important elements of Tonix’s proprietary TNX-102 SL composition. This patent is expected to provide TNX-102 SL with U.S. market exclusivity until 2034 upon NDA approval.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News